Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Eur Heart J
    July 2024
  1. AHMAD Y, Lansky AJ
    Periprocedural myocardial infarction: thresholds of (in)significance.
    Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093.
    >> Share

  2. JURADO-ROMAN A, Agudo-Quilez P
    Tailoring antithrombotic treatment in patients with acute myocardial infarction and cancer: virtue lies in balance.
    Eur Heart J. 2024 Jul 19:ehae445. doi: 10.1093.
    >> Share

  3. DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al
    Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
    Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093.
    >> Share

  4. FIGTREE GA, Gray MP
    Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yet.
    Eur Heart J. 2024;45:2407-2409.
    >> Share

    June 2024
  5. SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al
    Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
    Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093.
    >> Share

  6. VILAHUR G, Radike M, Badimon L
    Novel cardioprotective approaches in ischaemic heart disease.
    Eur Heart J. 2024;45:2109-2111.
    >> Share

  7. SCHLOTTER F, Huber K, Hassager C, Halvorsen S, et al
    Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular In
    Eur Heart J. 2024 Jun 18:ehae363. doi: 10.1093.
    >> Share

  8. PEDICINO D, Volpe M
    Weekly Journal Scan: do we need beta-blockers after myocardial infarction with preserved ejection fraction?
    Eur Heart J. 2024 Jun 14:ehae368. doi: 10.1093.
    >> Share

  9. COUGHLAN JJ, Durand R, Byrne RA
    An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late.
    Eur Heart J. 2024;45:2063-2065.
    >> Share

  10. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
    Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
    Eur Heart J. 2024;45:2052-2062.
    >> Share

  11. BEERKENS FJ, Bhatt DL
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
    Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
    >> Share

  12. CULLEN L, Greenslade J, Parsonage W, Stephensen L, et al
    Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h.
    Eur Heart J. 2024 Jun 6:ehae343. doi: 10.1093.
    >> Share

  13. LIUZZO G, Patrono C
    Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area.
    Eur Heart J. 2024 Jun 1:ehae304. doi: 10.1093.
    >> Share

  14. VERGALLO R, Pedicino D
    Weekly Journal Scan: Impella CP in myocardial infarction complicated by cardiogenic shock.
    Eur Heart J. 2024 Jun 1:ehae306. doi: 10.1093.
    >> Share

  15. UZOKOV J, Alyavi A, Alyavi B, Abdullaev A, et al
    How artificial intelligence can assist with ischaemic heart disease.
    Eur Heart J. 2024;45:1866-1868.
    >> Share

    May 2024
  16. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
    Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
    >> Share

  17. KWON O, Ahn JH, Koh JS, Park Y, et al
    Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
    Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
    >> Share

  18. CREA F
    The growing role of coronary computed tomography angiography, polygenic risk scores and electronic nudges in the management of ischaemic heart disease.
    Eur Heart J. 2024;45:1769-1773.
    >> Share

  19. NURMOHAMED NS, van Rosendael AR, Danad I, Ngo-Metzger Q, et al
    Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography.
    Eur Heart J. 2024;45:1783-1800.
    >> Share

  20. HARIK L, Gaudino M
    Coronary angiography and bypass surgery: born together and now going separate ways?
    Eur Heart J. 2024;45:1816-1818.
    >> Share

  21. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
    Coronary bypass surgery guided by computed tomography in a low-risk population.
    Eur Heart J. 2024;45:1804-1815.
    >> Share

  22. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
    Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
    Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
    >> Share

  23. CREA F
    Focus on ischaemic heart disease: prevention with colchicine, role of the brain-heart axis, new therapeutic targets for ischaemia-reperfusion injury.
    Eur Heart J. 2024;45:1577-1581.
    >> Share

  24. TAKAHARA M, Soga Y, Iida O
    Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization.
    Eur Heart J. 2024;45:1634-1643.
    >> Share

  25. AMPONSAH-OFFEH M, Tual-Chalot S, Stellos K
    Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury.
    Eur Heart J. 2024;45:1681-1683.
    >> Share

  26. YANG K, Gao R, Chen H, Hu J, et al
    Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition.
    Eur Heart J. 2024;45:1662-1680.
    >> Share

  27. ADLAM D, van Dijk FS, Loeys B
    Genetic testing in patients with unexplained coronary aneurysms or dilation.
    Eur Heart J. 2024;45:1610-1612.
    >> Share

  28. JONES DA, Beirne AM, Kelham M, Wynne L, et al
    Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
    Eur Heart J. 2024;45:1647-1658.
    >> Share

  29. XIAO Q, Xu Y, Wang S
    Gastropericardial fistula complicated by severe multi-vessel coronary spasm.
    Eur Heart J. 2024;45:1685.
    >> Share

  30. CHEN Z, Dazard JE, Khalifa Y, Motairek I, et al
    Artificial intelligence-based assessment of built environment from Google Street View and coronary artery disease prevalence.
    Eur Heart J. 2024;45:1540-1549.
    >> Share

  31. HEUSCH G, Kleinbongard P
    Cardioprotection research has left its comfort zone.
    Eur Heart J. 2024;45:1568-1570.
    >> Share

  32. VERGALLO R, Patrono C
    Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
    Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
    >> Share

    April 2024
  33. NGO LTH, Peng Y, Denman R, Yang I, et al
    Long-term outcomes after hospitalization for atrial fibrillation or flutter.
    Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093.
    >> Share

  34. GALIUTO L, Volpe M
    Weekly journal scan: excess incidence of unexpected health outcomes following myocardial infarction-broader paths for secondary prevention.
    Eur Heart J. 2024 Apr 15:ehae229. doi: 10.1093.
    >> Share

  35. BHATT AS, Johansen ND, Modin D, Claggett BL, et al
    Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
    Eur Heart J. 2024 Apr 10:ehae235. doi: 10.1093.
    >> Share

  36. VERGALLO R, Galiuto L
    Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
    Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
    >> Share

  37. CREA F
    The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
    Eur Heart J. 2024;45:1183-1187.
    >> Share

  38. KASKI JC, Al-Lamee R, Boden WE
    The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease.
    Eur Heart J. 2024;45:1201-1204.
    >> Share

  39. AMERI P, Bertero E, Lombardi M, Porto I, et al
    Ischaemic heart disease in patients with cancer.
    Eur Heart J. 2024;45:1209-1223.
    >> Share

  40. BYRNE R, Coughlan JJ, Rossello X, Ibanez B, et al
    The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes.
    Eur Heart J. 2024;45:1193-1195.
    >> Share

  41. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
    Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
    Eur Heart J. 2024;45:1285.
    >> Share

  42. WU VC, Yeh JK, Chen SW, Wu CL, et al
    Syphilis and cardiovascular risk: a Taiwanese registry.
    Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093.
    >> Share

  43. SAYAH N, Bhatt DL, Miller M, Brinton EA, et al
    Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
    Eur Heart J. 2024;45:1173-1176.
    >> Share

    March 2024
  44. LI L, Pang S, Starnecker F, Mueller-Myhsok B, et al
    Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
    Eur Heart J. 2024 Mar 29:ehae048. doi: 10.1093.
    >> Share

  45. WYLD M, Webster AC
    Myocardial infarction and stroke in patients with kidney failure: can we do better?
    Eur Heart J. 2024 Mar 27:ehae153. doi: 10.1093.
    >> Share

  46. TSUDA K, Nagamatsu W, Morii I
    A collateral channel from the bronchial artery in chronic total occlusion of proximal right coronary artery.
    Eur Heart J. 2024;45:1087.
    >> Share

  47. VILAHUR G, Radike M, Sutelman P, Ben-Aicha S, et al
    Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction.
    Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093.
    >> Share

  48. URSO S, Sadaba R, Dayan V
    Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
    Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
    >> Share

  49. VERGALLO R, Galiuto L
    Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
    Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
    >> Share

  50. GALLACHER PJ, Yeung D, Bell S, Shah ASV, et al
    Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study.
    Eur Heart J. 2024 Mar 1:ehae080. doi: 10.1093.
    >> Share

  51. CREA F
    Ischaemic heart disease: prevention, management, mechanisms, and new therapeutic targets.
    Eur Heart J. 2024;45:637-641.
    >> Share

  52. JANSEN TPJ, Wentzel JJ, Damman P
    Interplay between coronary bridging and high shear stress in the emergence of coronary vasospasm.
    Eur Heart J. 2024;45:737.
    >> Share

    February 2024
  53. KUMAR A, Vora K, Bhatt DL, Dharmakumar R, et al
    The Canadian Cardiovascular Society Classification of acute atherothrombotic myocardial infarction provides a novel staging scheme based on tissue injury severity.
    Eur Heart J. 2024 Feb 17:ehad821. doi: 10.1093.
    >> Share

  54. TARANTINI G, Putorti F, Nai Fovino L
    10-Year optical coherence tomography follow-up of 'full-plastic jacket' with bioresorbable vascular scaffolds.
    Eur Heart J. 2024;45:556.
    >> Share

  55. BARILE L, Marban E
    Injury minimization after myocardial infarction: focus on extracellular vesicles.
    Eur Heart J. 2024 Feb 15:ehae089. doi: 10.1093.
    >> Share

  56. NISHIHIRA K, Asano Y, Shibata Y
    Efficacy of paclitaxel-coated balloon angioplasty combined with intensive lipid-lowering therapy for ST-segment elevation myocardial infarction: insights from near-infrared spectroscopy.
    Eur Heart J. 2024 Feb 15:ehae073. doi: 10.1093.
    >> Share

  57. HOLT A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, et al
    Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study.
    Eur Heart J. 2024;45:475-484.
    >> Share

  58. MONTONE RA, Camilli M, Calvieri C, Magnani G, et al
    Exposome in ischaemic heart disease: beyond traditional risk factors.
    Eur Heart J. 2024;45:419-438.
    >> Share

  59. CHEONG HS, Chang Y, Kim Y, Kwon MJ, et al
    Human papillomavirus infection and cardiovascular mortality: a cohort study.
    Eur Heart J. 2024 Feb 7:ehae020. doi: 10.1093.
    >> Share

  60. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
    Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
    >> Share

  61. BOERHOUT CKM, Piek JJ, van de Hoef TP
    The microvascular resistance reserve: one size fits all, but mostly one.
    Eur Heart J. 2024;45:401.
    >> Share

  62. JANSEN TPJ, Crooijmans C, Damman P
    Microvascular resistance reserve, does one size fit all?
    Eur Heart J. 2024;45:399-400.
    >> Share

    January 2024
  63. HUET F, Mariano-Goulart D, Aguilhon S, Delbaere Q, et al
    Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial.
    Eur Heart J. 2024 Jan 30:ehae042. doi: 10.1093.
    >> Share

  64. SENIOR R, Khattar RS
    To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
    Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
    >> Share

  65. NAKAJIMA A, Okutsu M, Nakamura S
    Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy.
    Eur Heart J. 2024;45:315.
    >> Share

  66. NATARAJAN N, Dutta P
    'Training' of innate immunity following myocardial infarction exacerbates atherosclerosis.
    Eur Heart J. 2024 Jan 25:ehae024. doi: 10.1093.
    >> Share

  67. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    >> Share

  68. GOBEIL E, Bourgault J, Mitchell PL, Houessou U, et al
    Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
    Eur Heart J. 2024 Jan 19:ehad845. doi: 10.1093.
    >> Share

  69. ARNOLD N, Blaum C, Gossling A, Brunner FJ, et al
    C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project.
    Eur Heart J. 2024 Jan 18:ehad867. doi: 10.1093.
    >> Share

  70. LI Z, Zhang H, Lin S
    Functionally bicuspid aortic valve leads to myocardial ischaemia.
    Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
    >> Share

  71. VERGALLO R, Galiuto L
    Shedding the optical coherence tomography light on the treatment of complex coronary bifurcation lesions.
    Eur Heart J. 2024;45:159-160.
    >> Share

  72. GOULD KL, Johnson NP, Roby AE, Bui L, et al
    Coronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications.
    Eur Heart J. 2024;45:181-194.
    >> Share

  73. SHIMADA T, Otsuka K, Fukuda D
    Acute thrombus formation following stent implantation diagnosed by using intravascular polarimetry.
    Eur Heart J. 2024;45:145.
    >> Share

  74. CAMARO C, Aarts GWA, van Royen N
    Less concern about missing NSTEMIs, more prospective randomized controlled trials warranted.
    Eur Heart J. 2024;45:144.
    >> Share

  75. GLAESER J, Lopez-Ayala P, Mueller C
    Concern regarding missed non-ST-segment elevation myocardial infarctions when applying a single, pre-hospital cardiac troponin measurement.
    Eur Heart J. 2024;45:142-143.
    >> Share

  76. CREA F
    The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation.
    Eur Heart J. 2024;45:1-4.
    >> Share

  77. BAATEN CCFMJ, Nagy M, Bergmeier W, Spronk HMH, et al
    Platelet biology and function: plaque erosion vs. rupture.
    Eur Heart J. 2024;45:18-31.
    >> Share

    December 2023
  78. TAQUETI VR
    Leveraging global coronary flow assessments to inform revascularization benefit in chronic coronary disease: time to test total heart flow.
    Eur Heart J. 2023 Dec 28:ehad812. doi: 10.1093.
    >> Share

  79. PEDICINO D, Vergallo R
    More blood for patients with myocardial infarction and anaemia?
    Eur Heart J. 2023 Dec 23:ehad832. doi: 10.1093.
    >> Share

  80. REDD MA, Yoshikawa Y, Khan N, Waqar M, et al
    Acid-sensing ion channel 1a blockade reduces myocardial injury in rodent models of myocardial infarction.
    Eur Heart J. 2023 Dec 14:ehad793. doi: 10.1093.
    >> Share

  81. PIRIOU PG, Plessis J, Guerin P
    Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
    Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
    >> Share

  82. DONG Z, Hou L, Luo W, Pan LH, et al
    Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis.
    Eur Heart J. 2023 Dec 12:ehad787. doi: 10.1093.
    >> Share

  83. KHAN MS, Usman MS, Van Spall HGC, Greene SJ, et al
    Endpoint adjudication in cardiovascular clinical trials.
    Eur Heart J. 2023;44:4835-4846.
    >> Share

  84. ALFONSO F, Marschall A, Rivero F
    Revascularization for left main coronary artery disease.
    Eur Heart J. 2023;44:4893.
    >> Share

  85. PERSSON J, Ivert T, Omerovic E
    Observational studies are needed to complete the body of evidence for left main coronary artery disease revascularization strategies.
    Eur Heart J. 2023;44:4894.
    >> Share

    November 2023
  86. LU ZN, Yang Y, Song G
    A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
    Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
    >> Share

  87. VERGALLO R, Volpe M
    Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty?
    Eur Heart J. 2023 Nov 28:ehad792. doi: 10.1093.
    >> Share

  88. WENZL FA, Fox KAA, Luscher TF
    Towards personalized cardiovascular care: Global Registry of Acute Coronary Events 3.0 score heralds artificial intelligence era.
    Eur Heart J. 2023;44:4615-4616.
    >> Share

  89. PEDICINO D, Vergallo R
    Routine use of extracorporeal life support in cardiogenic shock after acute myocardial infarction: the jury is still out.
    Eur Heart J. 2023 Nov 18:ehad760. doi: 10.1093.
    >> Share

  90. PEDICINO D, Liuzzo G
    Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?
    Eur Heart J. 2023 Nov 18:ehad733. doi: 10.1093.
    >> Share

  91. LIU W, Song B, Li B
    Myocardial infarction caused by in situ thrombosis of a patent foramen ovale assessed by optical coherence tomography.
    Eur Heart J. 2023 Nov 15:ehad753. doi: 10.1093.
    >> Share

  92. HENRY CM, Oseran AS, Zheng Z, Dong H, et al
    Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in the United States.
    Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093.
    >> Share

  93. LUO J, Thomassen JQ, Nordestgaard BG, Tybjaerg-Hansen A, et al
    Neutrophil counts and cardiovascular disease.
    Eur Heart J. 2023 Nov 9:ehad649. doi: 10.1093.
    >> Share

  94. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
    Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
    Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.
    >> Share

  95. KIM H, Kang DY, Lee J, Choi Y, et al
    Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
    Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
    >> Share

  96. CREA F
    Hot topics in interventional cardiology: left main disease, heavily calcified coronary stenoses, and physiology-guided percutaneous coronary interventions.
    Eur Heart J. 2023;44:4295-4299.
    >> Share

  97. ALASNAG M
    Instantaneous wave-free ratio compared with fractional flow reserve: time for rethinking current recommendations.
    Eur Heart J. 2023;44:4385-4387.
    >> Share

  98. BYRNE RA, Fremes S, Capodanno D, Czerny M, et al
    2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
    Eur Heart J. 2023;44:4310-4320.
    >> Share

  99. JOHNSON NP, Ahn JM
    Left main PCI: beware the circumflex!
    Eur Heart J. 2023;44:4337-4339.
    >> Share

  100. BARBATO E, Gallinoro E, Abdel-Wahab M, Andreini D, et al
    Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group.
    Eur Heart J. 2023;44:4340-4356.
    >> Share

  101. WANG HY, Zhang R, Dou K, Huang Y, et al
    Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality.
    Eur Heart J. 2023;44:4324-4336.
    >> Share

    October 2023
  102. NAMBIEMA A, Lisan Q, Vaucher J, Perier MC, et al
    Healthy sleep score changes and incident cardiovascular disease in European prospective community-based cohorts.
    Eur Heart J. 2023 Oct 20:ehad657. doi: 10.1093.
    >> Share

  103. ARORA S, Zimmermann FM, Solberg OG, Nytroen K, et al
    Prognostic value of intravascular ultrasound early after heart transplantation.
    Eur Heart J. 2023 Oct 18:ehad648. doi: 10.1093.
    >> Share

  104. CREA F
    Acute coronary syndromes: new guidelines and new light shed on biomarkers and mechanisms of plaque instability.
    Eur Heart J. 2023;44:3707-3711.
    >> Share

  105. WENZL FA, Bruno F, Kraler S, Klingenberg R, et al
    Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes.
    Eur Heart J. 2023;44:3859-3871.
    >> Share

  106. NISSEN SE
    Plaque morphology, inflammation, and outcome: cautious and tempered interpretation warranted.
    Eur Heart J. 2023;44:3926-3928.
    >> Share

  107. GERHARDT T, Seppelt C, Abdelwahed YS, Meteva D, et al
    Culprit plaque morphology determines inflammatory risk and clinical outcomes in acute coronary syndrome.
    Eur Heart J. 2023;44:3911-3925.
    >> Share

  108. METEVA D, Vinci R, Seppelt C, Abdelwahed YS, et al
    Toll-like receptor 2, hyaluronan, and neutrophils play a key role in plaque erosion: the OPTICO-ACS study.
    Eur Heart J. 2023;44:3892-3907.
    >> Share

  109. FRANCK G
    Unravelling the heart's comic drama: can TLRs and hyaluronan metabolism stoke neutrophil rage in acute coronary syndrome?
    Eur Heart J. 2023;44:3908-3910.
    >> Share

  110. EMMERT MY, Burrello J, Wolint P, Hilbe M, et al
    Intracoronary delivery of extracellular vesicles from human cardiac progenitor cells reduces infarct size in porcine acute myocardial infarction.
    Eur Heart J. 2023 Oct 3:ehad636. doi: 10.1093.
    >> Share

  111. PEDICINO D, Liuzzo G
    An unexpected fall from GRACE.
    Eur Heart J. 2023;44:3501-3502.
    >> Share

    September 2023
  112. VERGALLO R, Volpe M
    Light the FIRE of revascularization in older patients with myocardial infarction.
    Eur Heart J. 2023 Sep 28:ehad638. doi: 10.1093.
    >> Share

  113. KI YJ, Han K, Kim HS, Han JK, et al
    Smoking and cardiovascular outcomes after percutaneous coronary intervention: a Korean study.
    Eur Heart J. 2023 Sep 26:ehad616. doi: 10.1093.
    >> Share

  114. WEINTRAUB WS, Boden WE
    Can we measurably improve the prediction of recurrent coronary artery disease events?
    Eur Heart J. 2023;44:3466-3468.
    >> Share

  115. CREA F
    Challenges and opportunities in prognostication: focus on ischaemic heart disease and atrial fibrillation.
    Eur Heart J. 2023;44:3391-3394.
    >> Share

  116. CHO SMJ, Koyama S, Honigberg MC, Surakka I, et al
    Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study.
    Eur Heart J. 2023;44:3456-3465.
    >> Share

  117. ARDISSINO M, Morley AP, Slob EAW, Schuermans A, et al
    Birth weight influences cardiac structure, function, and disease risk: evidence of a causal association.
    Eur Heart J. 2023 Sep 20:ehad631. doi: 10.1093.
    >> Share

  118. CREA F
    TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?
    Eur Heart J. 2023;44:3105-3109.
    >> Share

    August 2023
  119. BERRY C, McClure JD, Oldroyd KG
    Coronary revascularization guided by instantaneous wave-free ratio compared to fractional flow reserve: pooled 5-year mortality in the DEFINE-FLAIR and iFR-SWEDEHEART trials.
    Eur Heart J. 2023 Aug 27:ehad552. doi: 10.1093.
    >> Share

  120. EFTEKHARI A, Holck EN, Westra J, Olsen NT, et al
    Five-year major cardiovascular events are increased when coronary revascularization is guided by instantaneous wave-free ratio compared to fractional flow reserve: a pooled analysis of iFR-SWEDEHEART and DEFINE-FLAIR trials.
    Eur Heart J. 2023 Aug 27:ehad582. doi: 10.1093.
    >> Share

  121. GAUTIER A, Picard F, Ducrocq G, Elbez Y, et al
    New-onset atrial fibrillation in chronic coronary syndrome: the CLARIFY registry.
    Eur Heart J. 2023 Aug 27:ehad556. doi: 10.1093.
    >> Share

  122. BYRNE RA, Rossello X, Coughlan JJ, Barbato E, et al
    2023 ESC Guidelines for the management of acute coronary syndromes.
    Eur Heart J. 2023 Aug 25:ehad191. doi: 10.1093.
    >> Share

  123. RAO S, Nazarzadeh M, Canoy D, Li Y, et al
    Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.
    Eur Heart J. 2023 Aug 23:ehad535. doi: 10.1093.
    >> Share

  124. CAPODANNO D, Angiolillo DJ
    Personalised antiplatelet therapies for coronary artery disease: what the future holds.
    Eur Heart J. 2023;44:3059-3072.
    >> Share

  125. AARTS GWA, Camaro C, van Royen N
    Ready for rapid rule-out of acute myocardial infarction.
    Eur Heart J. 2023 Aug 18:ehad519. doi: 10.1093.
    >> Share

  126. MATTER MA, Paneni F, Libby P, Frantz S, et al
    Inflammation in acute myocardial infarction: the good, the bad and the ugly.
    Eur Heart J. 2023 Aug 17:ehad486. doi: 10.1093.
    >> Share

  127. PRENDERGAST BD, Patterson T, Redwood S
    Transcatheter aortic valve implantation in patients with severe aortic stenosis and cardiogenic shock: an important step forward.
    Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093.
    >> Share

  128. CREA F
    Coronary microvascular dysfunction: from Cinderella to Princess.
    Eur Heart J. 2023;44:2791-2794.
    >> Share

  129. KATUS HA, Giannitsis E
    Single high-sensitivity troponin sample below the limit of detection to safely rule out NSTEMI-ACS: is this enough?
    Eur Heart J. 2023;44:2859-2861.
    >> Share

  130. MORROW AJ, McFarlane R, Berry C
    Novel therapy for ischaemia with no obstructive coronary arteries.
    Eur Heart J. 2023;44:2829-2832.
    >> Share

  131. ENDAMENA GB, Le Moal J, Landolff Q
    Fast healing of an almost complete iatrogenic ascending aortic hematoma post-percutaneous recanalization for chronic total occlusion.
    Eur Heart J. 2023;44:2875.
    >> Share

  132. MCENTEGART M, Gori T
    How to treat left main coronary artery disease: the complementary lessons from trials and registries.
    Eur Heart J. 2023;44:2843-2845.
    >> Share

  133. PERSSON J, Yan J, Angeras O, Venetsanos D, et al
    PCI or CABG for left main coronary artery disease: the SWEDEHEART registry.
    Eur Heart J. 2023;44:2833-2842.
    >> Share

  134. ACHIM A, Johnson NP, Liblik K, Burckhardt A, et al
    Coronary steal: how many thieves are out there?
    Eur Heart J. 2023;44:2805-2814.
    >> Share

  135. AL ZAIDI M, Nickenig G, Zimmer S
    Emergency transcatheter aortic valve replacement in a 35-year-old patient with unicuspid aortic valve disease and cardiogenic shock.
    Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093.
    >> Share

  136. LIUZZO G, Patrono C
    Acute myocardial infarction is associated with faster age-related cognitive decline.
    Eur Heart J. 2023 Aug 1:ehad475. doi: 10.1093.
    >> Share

  137. VERGALLO R, Patrono C
    Machine learning and myocardial infarction diagnosis: sometimes you can't make it on your own.
    Eur Heart J. 2023 Aug 1:ehad467. doi: 10.1093.
    >> Share

  138. SANCHEZ-CABO F, Fuster V, Silla-Castro JC, Gonzalez G, et al
    Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study.
    Eur Heart J. 2023;44:2698-2709.
    >> Share

  139. VAN KLEI WA, van Waes JAR, Beattie WS
    Routine post-operative troponin surveillance after non-cardiac surgery: are we ready?
    Eur Heart J. 2023 Aug 1:ehad487. doi: 10.1093.
    >> Share

  140. ROHDE LE, McMurray JJV
    REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed.
    Eur Heart J. 2023 Aug 1:ehad488. doi: 10.1093.
    >> Share

    July 2023
  141. PEDERSEN CK, Stengaard C, Botker MT, Sondergaard HM, et al
    Accelerated -Rule-Out of acute Myocardial Infarction using prehospital copeptin and in-hospital troponin: The AROMI study.
    Eur Heart J. 2023 Jul 21:ehad447. doi: 10.1093.
    >> Share

  142. DE LEMOS JA, Berry JD
    Comparisons of multiple troponin assays for detecting chronic myocardial injury in the general population: redundant or complementary?
    Eur Heart J. 2023;44:2606-2608.
    >> Share

  143. DEL VAL D, Bastante T, Alfonso F
    A novel coronary artery healing pattern suggesting the axial progression of coronary plaques.
    Eur Heart J. 2023;44:2643.
    >> Share

  144. FAZEL R, Yeh RW, Cohen DJ, Rao SV, et al
    Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA.
    Eur Heart J. 2023 Jul 19:ehad430. doi: 10.1093.
    >> Share

  145. PEDICINO D, Liuzzo G
    Should I stent or should I go?
    Eur Heart J. 2023;44:2425-2426.
    >> Share

  146. CREA F
    Focus on ischaemic heart disease: from mechanisms to prevention and treatment.
    Eur Heart J. 2023;44:2351-2354.
    >> Share

  147. RUSSO M, Rinaldi R, Camilli M, Bonanni A, et al
    Air pollution and plaque healing in acute coronary syndromes.
    Eur Heart J. 2023;44:2403-2405.
    >> Share

  148. FYYAZ S, Papadakis M
    Fit to a fault? The paradox of coronary artery disease in veteran athletes.
    Eur Heart J. 2023;44:2400-2402.
    >> Share

  149. FREITAG MT, Haaf P, Zellweger MJ
    Severe myocardial ischemia detected in routine oncological positron emission tomography/computed tomography with 18F-fluorodeoxyglucose.
    Eur Heart J. 2023;44:2412.
    >> Share

  150. BERRY C, Kramer CM, Kunadian V, Patel TR, et al
    Great Debate: Computed tomography coronary angiography should be the initial diagnostic test in suspected angina.
    Eur Heart J. 2023;44:2366-2375.
    >> Share

  151. DE BOSSCHER R, Dausin C, Claus P, Bogaert J, et al
    Lifelong endurance exercise and its relation with coronary atherosclerosis.
    Eur Heart J. 2023;44:2388-2399.
    >> Share

  152. MENTE A, Dehghan M, Rangarajan S, O'Donnell M, et al
    Diet, cardiovascular disease, and mortality in 80 countries.
    Eur Heart J. 2023 Jul 6:ehad269. doi: 10.1093.
    >> Share

    June 2023
  153. BJORNSON E, Adiels M, Taskinen MR, Burgess S, et al
    Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study.
    Eur Heart J. 2023 Jun 26:ehad337. doi: 10.1093.
    >> Share

  154. CANDREVA A, Templin C
    Is Takotsubo syndrome just the tip of the iceberg in the clinical spectrum of coronary microvascular dysfunction?
    Eur Heart J. 2023;44:2254-2256.
    >> Share

  155. DONG F, Yin L, Sisakian H, Hakobyan T, et al
    Takotsubo syndrome is a coronary microvascular disease: experimental evidence.
    Eur Heart J. 2023;44:2244-2253.
    >> Share

  156. LOWRY MTH, Doudesis D, Boeddinghaus J, Kimenai DM, et al
    Troponin in early presenters to rule out myocardial infarction.
    Eur Heart J. 2023 Jun 23:ehad376. doi: 10.1093.
    >> Share

  157. SOURIJ H, Aziz F, Mangge H, von Lewinski D, et al
    SGLT2 inhibition could potentially impact inflammation in acute myocardial infarction.
    Eur Heart J. 2023 Jun 23:ehad404. doi: 10.1093.
    >> Share

  158. TRIMAILLE A, Marchandot B, Morel O
    Modulation of inflammatory response after myocardial infarction: one explanation for the cardiovascular benefit of empagliflozin in the EMMY trial?
    Eur Heart J. 2023 Jun 23:ehad257. doi: 10.1093.
    >> Share

  159. BOERHOUT CKM, Lee JM, de Waard GA, Mejia-Renteria H, et al
    Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry.
    Eur Heart J. 2023 Jun 23:ehad378. doi: 10.1093.
    >> Share

  160. GOEL K, Shah P, Jones BM, Korngold E, et al
    Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
    Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093.
    >> Share

  161. NEMET I, Li XS, Haghikia A, Li L, et al
    Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.
    Eur Heart J. 2023 Jun 21:ehad333. doi: 10.1093.
    >> Share

  162. ALEXANDRE A, Silveira J, Sa I
    Chronic intramyocardial dissecting haematoma: multimodality imaging.
    Eur Heart J. 2023;44:2132.
    >> Share

  163. AMIN H, Noor HA, Bardooli F, Yousif N, et al
    Implementation of a national primary percutaneous coronary intervention program for ST-segment elevation myocardial infarction in the Kingdom of Bahrain: an inspiring success story from a centre of excellence.
    Eur Heart J. 2023 Jun 17:ehad329. doi: 10.1093.
    >> Share

  164. SABOURET P, Biondi-Zoccai G, Banach M, Galli M, et al
    Modulation and personalization of therapy after acute coronary syndromes: the road to precision.
    Eur Heart J. 2023;44:1965-1967.
    >> Share

  165. VERGALLO R, Patrono C
    Lower income, higher risk: disparities in treatments and outcomes of patients with acute myocardial infarction.
    Eur Heart J. 2023 Jun 2:ehad348. doi: 10.1093.
    >> Share

    May 2023
  166. CREA F
    Ischaemic heart disease: from the celebration of Heberden's description of angina pectoris to novel therapeutic targets for angiogenesis and myocardial fibrosis.
    Eur Heart J. 2023;44:1669-1673.
    >> Share

  167. HEUSCH G, Botker HE, Ferdinandy P, Schulz R, et al
    Primordial non-responsiveness: a neglected obstacle to cardioprotection.
    Eur Heart J. 2023;44:1687-1689.
    >> Share

  168. GIGANTE B
    To be or not to be admitted to the emergency department for chest pain? A costly dilemma.
    Eur Heart J. 2023;44:1715-1717.
    >> Share

  169. ZHU D, Liu S, Huang K, Li J, et al
    Intrapericardial long non-coding RNA-Tcf21 antisense RNA inducing demethylation administration promotes cardiac repair.
    Eur Heart J. 2023;44:1748-1760.
    >> Share

  170. IDING A, Ten Cate-Hoek A, Ten Cate H
    Determining 'thrombogenicity' in patients with coronary artery disease: what's next?
    Eur Heart J. 2023;44:1729-1731.
    >> Share

  171. NISHI T, Kume T, Uemura S
    Resuscitated sudden cardiac arrest related to intraplaque haemorrhage and coronary artery spasm.
    Eur Heart J. 2023;44:1766.
    >> Share

  172. BAO XL, Dai Y, Lu L, Wang XQ, et al
    Vasostatin-2 associates with coronary collateral vessel formation in diabetic patients and promotes angiogenesis via angiotensin-converting enzyme 2.
    Eur Heart J. 2023;44:1732-1744.
    >> Share

  173. CAMARO C, Aarts GWA, Adang EMM, van Hout R, et al
    Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial.
    Eur Heart J. 2023;44:1705-1714.
    >> Share

  174. BODEN WE, Kaski JC, Berry C
    Reprising Heberden's description of angina pectoris after 250 years.
    Eur Heart J. 2023;44:1684-1686.
    >> Share

  175. EMRICH T, Hell M
    Plaque composition on ultra-high-resolution coronary computed tomography angiography with optical coherence tomography correlation.
    Eur Heart J. 2023;44:1765.
    >> Share

  176. VERGALLO R, Patrono C
    'Atom Heart Mothers': the risk of ischaemic heart disease in women with adverse pregnancy outcomes.
    Eur Heart J. 2023;44:1592-1593.
    >> Share

  177. HAN Y
    Chinese expert consensus on clinical application of percutaneous mechanical circulatory support devices in interventional therapy for patients with complex cardiovascular disease.
    Eur Heart J. 2023;44:1586-1588.
    >> Share

  178. UEMATSU M, Yamada R, Sato A
    Isolated septal myocardial infarction with non-obstructive coronary arteries.
    Eur Heart J. 2023 May 4:ehad252. doi: 10.1093.
    >> Share

    April 2023
  179. BEN-BARUCH GOLAN Y, Zahger D
    Routine troponin testing before non-cardiac surgery: does the evidence justify the consequences?
    Eur Heart J. 2023 Apr 26:ehad227. doi: 10.1093.
    >> Share

  180. VERGALLO R, Liuzzo G
    Intravascular imaging to guide percutaneous coronary intervention of complex lesions: time to renovate guidelines?
    Eur Heart J. 2023 Apr 26:ehad243. doi: 10.1093.
    >> Share

  181. LIAKOPOULOS OJ, Kuhn EW, Hellmich M, Schlomicher M, et al
    Statin loading before coronary artery bypass grafting: a randomized trial.
    Eur Heart J. 2023 Apr 22:ehad238. doi: 10.1093.
    >> Share

  182. GENEST J
    Transient very low LDL-C levels: a legacy effect for cardiovascular prevention?
    Eur Heart J. 2023;44:1418-1420.
    >> Share

  183. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality.
    Eur Heart J. 2023;44:1432-1445.
    >> Share

  184. CREA F
    Persistent challenges following percutaneous interventions: paravalvular regurgitation, in-stent restenosis, and antiplatelet treatment-related bleeding.
    Eur Heart J. 2023;44:1287-1290.
    >> Share

  185. KANG J, Rizas KD, Park KW, Chung J, et al
    Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis.
    Eur Heart J. 2023;44:1360-1370.
    >> Share

  186. NDREPEPA G, Kastrati A
    P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes.
    Eur Heart J. 2023;44:1371-1373.
    >> Share

  187. GIACOPPO D, Alvarez-Covarrubias HA, Koch T, Cassese S, et al
    Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
    Eur Heart J. 2023;44:1343-1357.
    >> Share

  188. GENTILE D, Iannaccone M, Chieffo A
    Drug-coated balloons: from treatment of in-stent restenosis to extended indications. What's next?
    Eur Heart J. 2023;44:1357-1359.
    >> Share

  189. FEDELE D, Foa A, Pizzi C
    Electrocardiographic tips in a young woman presenting with ST-elevation myocardial infarction.
    Eur Heart J. 2023 Apr 11:ehad178. doi: 10.1093.
    >> Share

  190. COLOMBO A, Leone PP
    Redefining the way to perform percutaneous coronary intervention: a view in search of evidence.
    Eur Heart J. 2023 Apr 11:ehad215. doi: 10.1093.
    >> Share

  191. PEDICINO D, Volpe M
    Higher hospital readmissions in blacks after acute myocardial infarction: healthcare inequality gaps to fill in secondary prevention.
    Eur Heart J. 2023 Apr 10:ehad179. doi: 10.1093.
    >> Share

  192. HIRANO KI, Higashi M, Nakajima K
    Remarkable regression of diffuse coronary atherosclerosis in patients with triglyceride deposit cardiomyovasculopathy.
    Eur Heart J. 2023;44:1191.
    >> Share

    March 2023
  193. NURMOHAMED NS, Kraaijenhof JM, Mayr M, Nicholls SJ, et al
    Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction.
    Eur Heart J. 2023 Mar 29:ehad161. doi: 10.1093.
    >> Share

  194. SAKAI K, Collet C, Matsuo H
    Improvement of angina after treating focal coronary artery disease undetected in resting conditions.
    Eur Heart J. 2023;44:1097.
    >> Share

  195. LIUZZO G, Patrono C
    Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease.
    Eur Heart J. 2023;44:1016-1017.
    >> Share

  196. CIARDETTI N, Nardi G, Di Mario C
    Direct high-frequency intravascular ultrasound visualization of drug delivery after paclitaxel urea eluting balloon angioplasty.
    Eur Heart J. 2023;44:1096.
    >> Share

  197. HONDA Y, Nishihira K, Shibata Y, Asada Y, et al
    Early-phase restenosis following directional coronary atherectomy and paclitaxel-coated balloon angioplasty: a histopathological analysis.
    Eur Heart J. 2023;44:1098.
    >> Share

  198. THIELE H, Desch S, Freund A
    Out-of-hospital cardiac arrest without ST-segment elevation: an alternative focus on priorities?
    Eur Heart J. 2023;44:1055-1057.
    >> Share

  199. JIANG Y, Huang J, Li G, Wang W, et al
    Ozone pollution and hospital admissions for cardiovascular events.
    Eur Heart J. 2023 Mar 10:ehad091. doi: 10.1093.
    >> Share

  200. OZKAN J
    Patient study highlights the need to talk about INOCA.
    Eur Heart J. 2023;44:788-789.
    >> Share

  201. SHEMESH E, Chevli PA, Islam T, German CA, et al
    Circulating ketone bodies and cardiovascular outcomes: the MESA study.
    Eur Heart J. 2023 Mar 6:ehad087. doi: 10.1093.
    >> Share

  202. LEE SH, Kim HK, Ahn JH, Kang MG, et al
    Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction.
    Eur Heart J. 2023 Mar 1:ehad088. doi: 10.1093.
    >> Share

  203. HOJO K, Otsuka K, Kasayuki N
    Plaque rupture after coronary CT angiography.
    Eur Heart J. 2023;44:782.
    >> Share

  204. MAJMUNDAR M, Doshi R, Patel KN, Zala H, et al
    Prevalence, trends, and outcomes of cardiovascular diseases in pregnant patients in the USA: 2010-19.
    Eur Heart J. 2023;44:726-737.
    >> Share

    February 2023

  205. Corrigendum to: Climate and environmental triggers of acute myocardial infarction.
    Eur Heart J. 2023 Feb 25:ehad105. doi: 10.1093.
    >> Share

  206. THOMAS PE, Vedel-Krogh S, Kamstrup PR, Nordestgaard BG, et al
    Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein.
    Eur Heart J. 2023 Feb 21:ehad055. doi: 10.1093.
    >> Share

  207. DIBBEN GO, Faulkner J, Oldridge N, Rees K, et al
    Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis.
    Eur Heart J. 2023;44:452-469.
    >> Share

  208. CREA F
    Optimal management of myocardial infarction: from invasive treatment to secondary prevention and rehabilitation.
    Eur Heart J. 2023;44:431-434.
    >> Share

  209. GRACE SL
    Evidence is indisputable that cardiac rehabilitation provides health benefits and event reduction: time for policy action.
    Eur Heart J. 2023;44:470-472.
    >> Share

  210. MEHTA SR, McGrath BP
    Anatomy vs. physiology: how should we achieve complete revascularization in acute coronary syndromes?
    Eur Heart J. 2023;44:485-487.
    >> Share

  211. PRICE S, Kaski JC, Al-Lamee R, Boden WE, et al
    The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischaemic heart disease.
    Eur Heart J. 2023;44:445-447.
    >> Share

  212. MORROW DA
    Prognostic interpretation of serial high-sensitivity cardiac troponin in patients presenting with suspected acute coronary syndrome.
    Eur Heart J. 2023;44:513-515.
    >> Share

  213. PAREEK M, Kragholm KH, Kristensen AMD, Vaduganathan M, et al
    Serial troponin-T and long-term outcomes in suspected acute coronary syndrome.
    Eur Heart J. 2023;44:502-512.
    >> Share

  214. YAMAMOTO H, Fujii M, Takaya T
    High-risk calcified plaque preoperatively detected by non-contrast T1-weighted magnetic resonance imaging and electrocardiogram-gated computed tomography.
    Eur Heart J. 2023;44:534.
    >> Share

  215. OZKAN J
    Small country big difference: how one physician's vision became a reality and transformed acute myocardial infarction management in the Republic of Mauritius.
    Eur Heart J. 2023 Feb 3:ehad012. doi: 10.1093.
    >> Share

  216. THYGESEN K, Jaffe AS
    Potential risks of non-cardiac peri-operative myocardial infarction/injury.
    Eur Heart J. 2023 Feb 1:ehac768. doi: 10.1093.
    >> Share

  217. GERSH BJ, De Mets D
    Revascularization in ischaemic cardiomyopathy: how to interpret current evidence.
    Eur Heart J. 2023;44:365-367.
    >> Share

  218. VERGALLO R, Volpe M
    A gender issue in the diagnostic imaging work-up of stable coronary artery disease? Insights from DISCHARGE.
    Eur Heart J. 2023;44:340-341.
    >> Share

    January 2023
  219. PUELACHER C, Gualandro DM, Glarner N, Lurati Buse G, et al
    Long-term outcomes of perioperative myocardial infarction/injury after non-cardiac surgery.
    Eur Heart J. 2023 Jan 27:ehac798. doi: 10.1093.
    >> Share

  220. CREA F
    Ischaemic heart disease: antithrombotic treatment and new therapeutic targets.
    Eur Heart J. 2023;44:239-242.
    >> Share

  221. KATO ET, Morrow DA, Guo J, Berg DD, et al
    Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
    Eur Heart J. 2023;44:293-300.
    >> Share

  222. GALLI M, Ortega-Paz L, Angiolillo DJ
    Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot.
    Eur Heart J. 2023;44:236.
    >> Share

  223. XIE C, Zhang Y, Lin J
    Are there other factors that influence the assessment of bleeding risk comparing potent P2Y12 inhibitors with clopidogrel?
    Eur Heart J. 2023;44:235.
    >> Share

  224. CREA F
    Hot topics in ischaemic heart disease: polygenic risk scores, coronary microvascular dysfunction, myocardial injury, and diagnostic role of imaging.
    Eur Heart J. 2023;44:73-76.
    >> Share

  225. NEGLIA D, Liga R, Gimelli A, Podlesnikar T, et al
    Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry.
    Eur Heart J. 2023;44:142-158.
    >> Share

  226. PEPINE CJ, Bairey Merz CN
    Heart and brain interactions: is small vessel disease a link?
    Eur Heart J. 2023;44:126-128.
    >> Share

  227. MEJIA-RENTERIA H, Travieso A, Matias-Guiu JA, Yus M, et al
    Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study).
    Eur Heart J. 2023;44:113-125.
    >> Share

  228. RAY KK, Raal FJ, Kallend DG, Jaros MJ, et al
    Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
    Eur Heart J. 2023;44:129-138.
    >> Share

  229. OMRAN H
    Troponin for risk stratification after CABG: just one piece of the puzzle.
    Eur Heart J. 2023;44:163-164.
    >> Share

  230. CHEN T, Zhou H, Guo J, Chen Y, et al
    Intravascular ultrasound and ultrasonic flow ratio-guided zero-contrast rotational atherectomy for calcified coronary lesions.
    Eur Heart J. 2023;44:166.
    >> Share

    December 2022
  231. TARDIF JC, Pfeffer MA, Dube MP
    Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome.
    Eur Heart J. 2022;43:5062-5063.
    >> Share

  232. SNIDERMAN AD
    dal-GenE was negative-not positive except for COVID-19.
    Eur Heart J. 2022;43:5061.
    >> Share

  233. FUKAMACHI D, Okumura Y
    Growing giant coronary artery aneurysm.
    Eur Heart J. 2022;43:5065.
    >> Share

  234. HUBER K
    Platelet antiaggregation after an acute coronary syndrome: what about the elderly?
    Eur Heart J. 2022;43:5045-5046.
    >> Share

  235. GIBLETT JP, Matetic A, Jenkins D, Ng CY, et al
    Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry.
    Eur Heart J. 2022;43:5020-5032.
    >> Share

  236. ALFONSO F, Aguilar R, Reyes G
    Management of post-infarction ventricular septal defects: are we moving forward?
    Eur Heart J. 2022;43:5033-5036.
    >> Share

  237. LEE JM, Kim HK, Park KH, Choo EH, et al
    Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
    Eur Heart J. 2022 Dec 20:ehac763. doi: 10.1093.
    >> Share

  238. DANCHIN N
    Improved long-term survival after acute myocardial infarction: the success of comprehensive care from the acute stage to the long term.
    Eur Heart J. 2022 Dec 20:ehac714. doi: 10.1093.
    >> Share

  239. DAVIDSON JA, Banerjee A, Douglas I, Leyrat C, et al
    Primary prevention of acute cardiovascular events by influenza vaccination: an observational study.
    Eur Heart J. 2022 Dec 20:ehac737. doi: 10.1093.
    >> Share

  240. COUGHLAN JJ, Ibanez B
    Reperfusion in ST-elevation myocardial infarction: delays have dangerous ends.
    Eur Heart J. 2022 Dec 14:ehac723. doi: 10.1093.
    >> Share

  241. HOLMSTROM L, Juntunen S, Vahatalo J, Pakanen L, et al
    Plaque histology and myocardial disease in sudden coronary death: the Fingesture study.
    Eur Heart J. 2022;43:4923-4930.
    >> Share

  242. NISHIHIRA K, Shibata Y, Asada Y
    Intraplaque haemorrhage in rapidly progressing coronary atheroma: insights from histopathological analysis of atherectomy specimens.
    Eur Heart J. 2022;43:4964.
    >> Share

  243. VERGALLO R, Patrono C
    A BRIGHT outlook for bivalirudin in patients with ST-segment elevation myocardial infarction.
    Eur Heart J. 2022 Dec 7:ehac732. doi: 10.1093.
    >> Share

  244. O'SULLIVAN JW, Ashley EA, Elliott PM
    Polygenic risk scores for the prediction of cardiometabolic disease.
    Eur Heart J. 2022 Dec 7:ehac648. doi: 10.1093.
    >> Share

  245. EL-CHOULI M, Meddis A, Christensen DM, Gerds TA, et al
    Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study.
    Eur Heart J. 2022 Dec 7:ehac727. doi: 10.1093.
    >> Share

  246. COSTA F, Montalto C, Branca M, Hong SJ, et al
    Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.
    Eur Heart J. 2022 Dec 7:ehac706. doi: 10.1093.
    >> Share

  247. LIBERALE L, Puspitasari YM, Ministrini S, Akhmedov A, et al
    JCAD promotes arterial thrombosis through PI3K/Akt modulation: a translational study.
    Eur Heart J. 2022 Dec 5:ehac641. doi: 10.1093.
    >> Share

  248. JAMAL J, Idris H, Faour A, Yang W, et al
    Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention.
    Eur Heart J. 2022 Dec 2:ehac661. doi: 10.1093.
    >> Share

  249. HAN Y
    Chinese guidelines for percutaneous coronary intervention in patients with left main bifurcation disease.
    Eur Heart J. 2022 Dec 2:ehac625. doi: 10.1093.
    >> Share

  250. PEDICINO D, Liuzzo G
    Mind the map: a multi-omic approach to post-ischaemic cardiac remodelling paves the way for future cardiovascular research.
    Eur Heart J. 2022;43:4677-4678.
    >> Share

  251. LECOEUR E, Domenge O, Fayol A, Jannot AS, et al
    Epidemiology of heart failure in young adults: a French nationwide cohort study.
    Eur Heart J. 2022 Dec 1:ehac651. doi: 10.1093.
    >> Share

    November 2022
  252. CHRISTENSEN DM, Schjerning AM, Smedegaard L, Charlot MG, et al
    Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study.
    Eur Heart J. 2022 Nov 26:ehac667. doi: 10.1093.
    >> Share

  253. HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al
    Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry.
    Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093.
    >> Share

  254. CREA F
    Controversies in cardiac surgery: left main coronary disease, arterial myocardial revascularization, and prosthetic valves in dialysis.
    Eur Heart J. 2022;43:4603-4605.
    >> Share

  255. KITE TA, Bountziouka V, Ladwiniec A
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: risk and reward?
    Eur Heart J. 2022;43:4661.
    >> Share

  256. ALADIN AI, Zhang C, Waksman R
    Timing of early invasive strategy in patients with non-ST-elevation acute coronary syndrome.
    Eur Heart J. 2022;43:4660.
    >> Share

  257. GONG X, Shen J, Liu L, Xiao Z, et al
    Pulmonary trunk compression due to multiple aneurysms associated with a coronary-pulmonary artery fistula.
    Eur Heart J. 2022;43:4662.
    >> Share

  258. TAGGART DP, Audisio K, Gerry S, Robinson NB, et al
    Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial.
    Eur Heart J. 2022;43:4644-4652.
    >> Share

  259. HOLMSTROM L, Chugh SS
    How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation.
    Eur Heart J. 2022 Nov 15. pii: 6827956. doi: 10.1093.
    >> Share

  260. VAN DEN BROEK WWA, Ten Berg JM
    Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?
    Eur Heart J. 2022;43:4599-4600.
    >> Share

  261. BONACA MP, Im K, Magnani G, Bansilal S, et al
    Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2022 Nov 11. pii: 6823782. doi: 10.1093.
    >> Share

  262. PATHAK S, Lai FY, Miksza J, Petrie MC, et al
    Surgical or Percutaneous Coronary Revascularisation for Heart Failure: An In Silico Model using Routinely Collected Health Data to Emulate a Clinical Trial.
    Eur Heart J. 2022 Nov 9. pii: 6815617. doi: 10.1093.
    >> Share

  263. HEUTS S, Gollmann-Tepekoylu C, Denessen EJS, Olsthoorn JR, et al
    Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications.
    Eur Heart J. 2022 Nov 7. pii: 6807330. doi: 10.1093.
    >> Share

  264. FONSECA HAR, Furtado RHM, Zimerman A, Lemos PA, et al
    Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial.
    Eur Heart J. 2022;43:4378-4388.
    >> Share

  265. VARDENY O
    Influenza vaccine in cardiovascular disease: time to move the needle.
    Eur Heart J. 2022;43:4389-4391.
    >> Share

    October 2022
  266. GARCIA R, Marijon E, Karam N, Narayanan K, et al
    Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study.
    Eur Heart J. 2022 Oct 28. pii: 6776117. doi: 10.1093.
    >> Share

  267. HEYNE S, Macherey S, Meertens MM, Braumann S, et al
    Coronary angiography after cardiac arrest without ST-elevation myocardial infarction: a network meta-analysis.
    Eur Heart J. 2022 Oct 27. pii: 6775293. doi: 10.1093.
    >> Share

  268. VERGALLO R, Volpe M
    Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR.
    Eur Heart J. 2022 Oct 26. pii: 6774407. doi: 10.1093.
    >> Share

  269. XIAO Q, Pu X, Wei X, Chen M, et al
    Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion.
    Eur Heart J. 2022 Oct 17. pii: 6761762. doi: 10.1093.
    >> Share

  270. TYBJAERG-HANSEN A, Nordestgaard LT, Christoffersen M
    Pharmacogenetics-guided CETP inhibition: an open question?
    Eur Heart J. 2022;43:3957-3959.
    >> Share

  271. TARDIF JC, Pfeffer MA, Kouz S, Koenig W, et al
    Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.
    Eur Heart J. 2022;43:3947-3956.
    >> Share

  272. VERGALLO R, Liuzzo G
    The REVIVED-BCIS2 trial: percutaneous coronary intervention vs. optimal medical therapy for stable patients with severe ischaemic cardiomyopathy.
    Eur Heart J. 2022 Oct 10. pii: 6754626. doi: 10.1093.
    >> Share

  273. VERGALLO R, Liuzzo G
    Coronary artery calcium scoring for cardiovascular risk stratification: more pitfalls than advantages?
    Eur Heart J. 2022;43:3510-3511.
    >> Share

  274. GOTO S, Goto S
    Potent antithrombotic treatments in Asian vs. non-Asian patients.
    Eur Heart J. 2022;43:3553-3555.
    >> Share

  275. HORI M, Zhu J, Liang Y, Bhatt DL, et al
    Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial.
    Eur Heart J. 2022;43:3542-3552.
    >> Share

    September 2022
  276. ARMSTRONG PW, Bates ER, Gaudino M
    Left main coronary disease: evolving management concepts.
    Eur Heart J. 2022 Sep 29. pii: 6731216. doi: 10.1093.
    >> Share

  277. HESS CN, Bonaca MP
    Risk of remnants and remnant risk in peripheral artery disease.
    Eur Heart J. 2022;43:3270-3272.
    >> Share

  278. MARQUINA C, Lacaze P, Tiller J, Riaz M, et al
    Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis.
    Eur Heart J. 2022;43:3243-3254.
    >> Share

  279. VERGALLO R, Pedicino D
    Which mechanical circulatory support device in acute myocardial infarction complicated by cardiogenic shock?
    Eur Heart J. 2022 Sep 6. pii: 6692466. doi: 10.1093.
    >> Share

  280. CREA F
    Non-invasive diagnosis, antithrombotic treatment, and invasive management of ischaemic heart disease.
    Eur Heart J. 2022;43:3087-3091.
    >> Share

  281. NADARAJAH R, Wu J, Hurdus B, Asma S, et al
    The collateral damage of COVID-19 to cardiovascular services: a meta-analysis.
    Eur Heart J. 2022;43:3164-3178.
    >> Share

  282. SPIRITO A, Cao D, Mehran R
    Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon.
    Eur Heart J. 2022;43:3145-3147.
    >> Share

  283. LANCELLOTTI P, Go YY, Nchimi A
    Stress imaging versus fractional flow reserve: what comes first-the chicken or the egg?
    Eur Heart J. 2022;43:3129-3131.
    >> Share

  284. DRIESSEN RS, van Diemen PA, Raijmakers PG, Knuuti J, et al
    Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study.
    Eur Heart J. 2022;43:3118-3128.
    >> Share

  285. KITE TA, Kurmani SA, Bountziouka V, Cooper NJ, et al
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2022;43:3148-3161.
    >> Share

  286. GUEDENEY P, Thiele H, Collet JP
    Timing of invasive management of NSTE-ACS: is the time up for early management?
    Eur Heart J. 2022;43:3161-3163.
    >> Share

    August 2022
  287. VON LEWINSKI D, Kolesnik E, Tripolt NJ, Pferschy PN, et al
    Empagliflozin in acute Myocardial Infarction: the EMMY trial.
    Eur Heart J. 2022 Aug 29. pii: 6677315. doi: 10.1093.
    >> Share

  288. HARRINGTON J, Anker S, Butler J
    Putting the Puzzle Together: SGLT2 Inhibitors from Prevention to Treatment of Heart Failure.
    Eur Heart J. 2022 Aug 29. pii: 6677316. doi: 10.1093.
    >> Share

  289. GIDDING SS, Colangelo LA, Nwabuo CC, Lewis CE, et al
    PDAY risk score predicts cardiovascular events in young adults: the CARDIA study.
    Eur Heart J. 2022;43:2892-2900.
    >> Share

    July 2022
  290. DOLEJSI T, Delgobo M, Schuetz T, Tortola L, et al
    Adult T-cells impair neonatal cardiac regeneration.
    Eur Heart J. 2022;43:2698-2709.
    >> Share


  291. Corrigendum to: Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry.
    Eur Heart J. 2022 Jul 6. pii: 6632321. doi: 10.1093.
    >> Share

  292. GAUDINO M, Farkouh ME, Stone GW
    Left main revascularization: an evidence-based reconciliation.
    Eur Heart J. 2022;43:2421-2424.
    >> Share

  293. FISCHER J, Godecke A, Kelm M, Heusch G, et al
    Master switches in cardiac ischaemia: the Collaborative Research Center (CRC) 1116 of the German Research Foundation.
    Eur Heart J. 2022;43:2350-2351.
    >> Share

    June 2022
  294. CREA F
    Antiplatelet treatment of acute coronary syndromes: novel clinical and translational perspectives.
    Eur Heart J. 2022;43:2253-2256.
    >> Share

  295. ZHU H, Chen T, Huang J
    An attempt to better show some results such as the comparison of mortality and major adverse cardiovascular events between the abnormal and normal coronary flow reserve cohorts.
    Eur Heart J. 2022;43:2338-2339.
    >> Share

  296. SCHIELE F, Meneveau N
    NSTEMI management: a fall from GRACE?
    Eur Heart J. 2022;43:2300-2302.
    >> Share

  297. TAKEI Y, Abe N, Bohgaki M, Kasahara H, et al
    Paradoxical enlargement of immunoglobulin G4 (IgG4)-related coronary aneurysms despite controlling serum IgG4 level.
    Eur Heart J. 2022;43:2250.
    >> Share

  298. CACHEUX M, Akar FG
    A novel exosome-based therapy for post-MI arrhythmias.
    Eur Heart J. 2022;43:2157-2159.
    >> Share

    May 2022
  299. GANESANANTHAN S, Rajkumar CA, Foley M, Thompson D, et al
    Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
    Eur Heart J. 2022 May 26. pii: 6593472. doi: 10.1093.
    >> Share

  300. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    >> Share

  301. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
    Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
    Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
    >> Share

  302. SPOSITO AC
    Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular risk.
    Eur Heart J. 2022;43:1861-1863.
    >> Share

  303. KRALER S, Wenzl FA, Georgiopoulos G, Obeid S, et al
    Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes.
    Eur Heart J. 2022;43:1849-1860.
    >> Share

  304. WANG J, Chen H, Zhang L
    Coronary artery fistula bypassed the left main coronary artery blocked by a large cardiogenic thrombus.
    Eur Heart J. 2022;43:1885.
    >> Share

  305. LU X, Liu Z, Cui Q, Liu F, et al
    A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
    Eur Heart J. 2022;43:1702-1711.
    >> Share

  306. HAGEMAN SHJ, McKay AJ, Ueda P, Gunn LH, et al
    Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Eur Heart J. 2022;43:1715-1727.
    >> Share

  307. FRANTZ S, Hundertmark MJ, Schulz-Menger J, Bengel FM, et al
    Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.
    Eur Heart J. 2022 May 4. pii: 6578707. doi: 10.1093.
    >> Share

    April 2022
  308. CREA F
    Inflammation, targeted proteomics, and microvascular dysfunction: the new frontiers of ischaemic heart disease.
    Eur Heart J. 2022;43:1517-1520.
    >> Share

  309. STEFFENS S, Nahrendorf M, Madonna R
    Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies.
    Eur Heart J. 2022;43:1533-1541.
    >> Share

  310. KELSHIKER MA, Seligman H, Howard JP, Rahman H, et al
    Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1582-1593.
    >> Share

  311. MORICI N, De Servi S, De Luca L, Crimi G, et al
    Management of acute coronary syndromes in older adults.
    Eur Heart J. 2022;43:1542-1553.
    >> Share

  312. KELSHIKER MA, Seligman H, Howard JP, Rahman H, et al
    Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1582-1593.
    >> Share

  313. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    >> Share

  314. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
    Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
    Eur Heart J. 2022;43:1516.
    >> Share

  315. SAMMONS E, Hopewell JC, Chen F, Stevens W, et al
    Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
    Eur Heart J. 2022;43:1416-1424.
    >> Share

  316. BATRA G, Aktaa S, Wallentin L, Maggioni AP, et al
    Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).
    Eur Heart J. 2022 Apr 5. pii: 6563567. doi: 10.1093.
    >> Share

    March 2022
  317. BUCCIARELLI-DUCCI C, Ajmone-Marsan N, Di Carli M, Nicol E, et al
    The year in cardiovascular medicine 2021: imaging.
    Eur Heart J. 2022;43:1288-1295.
    >> Share

  318. BYRNE RA, Rai H, Colleran R
    Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus?
    Eur Heart J. 2022;43:1331-1333.
    >> Share

  319. HAN Y
    Chinese expert consensus statement on dual antiplatelet therapy in patients with coronary artery disease.
    Eur Heart J. 2022;43:1283-1285.
    >> Share

  320. ROMAGUERA R, Salinas P, Gomez-Lara J, Brugaletta S, et al
    Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
    Eur Heart J. 2022;43:1320-1330.
    >> Share

  321. OKA S, Endo H, Takagi K, Yamagata K, et al
    Mechanical coronary artery stenosis induced by active fixation left ventricular lead: a case of acute complication after cardiac resynchronization therapy device implantation.
    Eur Heart J. 2022;43:1271.
    >> Share

  322. THYGESEN K, Jaffe AS
    Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting.
    Eur Heart J. 2022 Mar 17. pii: 6549761. doi: 10.1093.
    >> Share

  323. HAN Y, Li Y
    Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve?
    Eur Heart J. 2022 Mar 17. pii: 6549760. doi: 10.1093.
    >> Share

  324. TURGEON RD, Koshman SL, Dong Y, Graham MM, et al
    P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
    Eur Heart J. 2022 Mar 17. pii: 6549798. doi: 10.1093.
    >> Share

  325. TUAL-CHALOT S, Stellos K
    Chrono-pharmacology-based antiplatelet therapy for acute myocardial infarction.
    Eur Heart J. 2022 Mar 10. pii: 6546087. doi: 10.1093.
    >> Share

  326. DAWKINS JF, Ehdaie A, Rogers R, Soetkamp D, et al
    Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
    Eur Heart J. 2022 Mar 9. pii: 6545456. doi: 10.1093.
    >> Share

  327. TAN S, White HD, Layland J
    Heparin use in acute coronary syndromes and cardiovascular interventions: habit or evidence based?
    Eur Heart J. 2022;43:1008-1011.
    >> Share

  328. SILVAIN J, Hausenloy D, Zeitouni M
    Appropriate criteria for the definition of Type 4a MI.
    Eur Heart J. 2022;43:1013-1014.
    >> Share

    February 2022
  329. MOLEDINA SM, Kontopantelis E, Wijeysundera HC, Banerjee S, et al
    Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study.
    Eur Heart J. 2022 Feb 24. pii: 6529720. doi: 10.1093.
    >> Share

  330. ZENG C, Rosenberg L, Li X, Djousse L, et al
    Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension.
    Eur Heart J. 2022 Feb 24. pii: 6535634. doi: 10.1093.
    >> Share

  331. PRICE S, Katz J, Kaufmann CC, Huber K, et al
    The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart disease.
    Eur Heart J. 2022;43:800-806.
    >> Share

  332. SHRAUNER W, Lord EM, Nguyen XT, Song RJ, et al
    Frailty and cardiovascular mortality in more than 3 million US Veterans.
    Eur Heart J. 2022;43:818-826.
    >> Share

  333. VAROTTO L, De Boni A, Iannucci G, Caprioglio F, et al
    Uncommon intravascular lithotripsy for the treatment of subclavian steal syndrome: a case presenting with concomitant acute coronary syndrome and transient ischaemic attack.
    Eur Heart J. 2022;43:840.
    >> Share

  334. LIUZZO G, Volpe M
    Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate.
    Eur Heart J. 2022 Feb 21. pii: 6533241. doi: 10.1093.
    >> Share

  335. OMRAN H, Deutsch MA, Groezinger E, Zittermann A, et al
    High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making.
    Eur Heart J. 2022 Feb 15. pii: 6528587. doi: 10.1093.
    >> Share

  336. LIUZZO G, Volpe M
    PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fraction.
    Eur Heart J. 2022;43:559-560.
    >> Share

  337. POLZL L, Thielmann M, Cymorek S, Nagele F, et al
    Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.
    Eur Heart J. 2022 Feb 9. pii: 6525341. doi: 10.1093.
    >> Share

  338. DE CATERINA R, Liga R, Boden WE
    Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence.
    Eur Heart J. 2022;43:387-390.
    >> Share

    January 2022
  339. BRAUNWALD E
    How to live to 100 before developing clinical coronary artery disease: a suggestion.
    Eur Heart J. 2022;43:249-250.
    >> Share

  340. SLIWICKA O, Damman P, Habets J
    Stress dynamic CT perfusion in the evaluation of acute coronary syndrome.
    Eur Heart J. 2022;43:244.
    >> Share

  341. CREA F
    Hot topics in ischaemic heart disease: revascularization, hibernation, type 2 infarction, and proteomics.
    Eur Heart J. 2022;43:89-92.
    >> Share

  342. NEWBY LK
    A new biomarker of acute coronary ischaemia: from bench to bedside?
    Eur Heart J. 2022;43:164-166.
    >> Share

  343. RYAN M, Morgan H, Chiribiri A, Nagel E, et al
    Myocardial viability testing: all STICHed up, or about to be REVIVED?
    Eur Heart J. 2022;43:118-126.
    >> Share

  344. CUBEDO J, Padro T, Vilahur G, Crea F, et al
    Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events.
    Eur Heart J. 2022;43:153-163.
    >> Share

  345. QUADRI G, Tomassini F, Cerrato E, Varbella F, et al
    Emergency treatment of a giant coronary aneurysm: percutaneous intervention with coronary and peripheral tools.
    Eur Heart J. 2022;43:168.
    >> Share

  346. DEMIR OM, Rahman H, van de Hoef TP, Escaned J, et al
    Invasive and non-invasive assessment of ischaemia in chronic coronary syndromes: translating pathophysiology to clinical practice.
    Eur Heart J. 2022;43:105-117.
    >> Share

    December 2021
  347. WANG R, Serruys PW, Gao C, Hara H, et al
    Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.
    Eur Heart J. 2021;43:56-67.
    >> Share

  348. NICOLAS J, Giustino G, Dangas G
    Periprocedural myocardial infarction: multiple definitions and still a quest for consensus.
    Eur Heart J. 2021 Dec 21. pii: 6471447. doi: 10.1093.
    >> Share

  349. LOZANO I, Vegas JM, Rondan J
    Percutaneous intervention in patients with cancer: can we offer an improvement in safety?
    Eur Heart J. 2021;42:4981.
    >> Share

  350. WHITE HD, Schwartz GG, Szarek M, Bhatt DL, et al
    Alirocumab after acute coronary syndrome in patients with a history of heart failure.
    Eur Heart J. 2021 Dec 18. pii: 6469637. doi: 10.1093.
    >> Share

  351. GALLI M, Benenati S, Franchi F, Rollini F, et al
    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
    Eur Heart J. 2021 Dec 16. pii: 6464193. doi: 10.1093.
    >> Share

  352. CREA F
    Percutaneous coronary interventions: more complex than fixing stenoses.
    Eur Heart J. 2021;42:4607-4611.
    >> Share

  353. WHITE HD
    Cardiac death should be the primary endpoint for revascularization trials and meta-analyses.
    Eur Heart J. 2021;42:4697-4698.
    >> Share

  354. AL-LAMEE R, Mintz GS
    What are the PROSPECTs and clinical implications of vulnerable plaque?
    Eur Heart J. 2021;42:4680-4682.
    >> Share

  355. KEDHI E, Berta B, Roleder T, Hermanides RS, et al
    Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial.
    Eur Heart J. 2021;42:4671-4679.
    >> Share

  356. AL-LAMEE R, Mintz GS
    What are the PROSPECTs and clinical implications of vulnerable plaque?
    Eur Heart J. 2021;42:4680-4682.
    >> Share

    November 2021
  357. EGGERS KM, James SK, Lindahl B
    Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?
    Eur Heart J. 2021 Nov 24. pii: 6438090. doi: 10.1093.
    >> Share

  358. BOR WL, Ten Berg JM
    Known or new atrial fibrillation in patients with acute coronary syndrome: what's the difference?
    Eur Heart J. 2021;42:4562-4564.
    >> Share

  359. DE SILVA R, Cheng K
    Microvascular angina: quo tendimus?
    Eur Heart J. 2021;42:4601-4604.
    >> Share

  360. SHIMOKAWA H, Suda A, Takahashi J, Berry C, et al
    Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group.
    Eur Heart J. 2021;42:4592-4600.
    >> Share

  361. PITT B, Ferreira JP, Zannad F
    Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI.
    Eur Heart J. 2021 Nov 12. pii: 6425576. doi: 10.1093.
    >> Share

  362. CHIKWE J, Alfieri OR
    The optimal strategy for multivessel coronary revascularization.
    Eur Heart J. 2021 Nov 11. pii: 6425621. doi: 10.1093.
    >> Share

  363. WINTHER S, Schmidt SE, Knuuti J, Bottcher M, et al
    Selecting the right cohorts and endpoints for the validation of pre-test probability models for obstructive coronary artery disease.
    Eur Heart J. 2021;42:4402-4403.
    >> Share

  364. DERIMAY F, Finet G, Rioufol G
    Coronary artery stenosis prediction does not mean coronary artery stenosis obstruction.
    Eur Heart J. 2021;42:4401.
    >> Share

  365. EGIDY ASSENZA G, Dimopoulos K, Budts W, Donti A, et al
    Management of acute cardiovascular complications in pregnancy.
    Eur Heart J. 2021;42:4224-4240.
    >> Share

    October 2021
  366. BIAN L, Fang Z, Qian H, Wu Z, et al
    Dumbbell on the heart: two giant left coronary artery aneurysms in an adolescent.
    Eur Heart J. 2021;42:4195.
    >> Share

  367. AHN JM, Zimmermann FM, Arora S, Solberg OG, et al
    Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.
    Eur Heart J. 2021 Oct 19. pii: 6401958. doi: 10.1093.
    >> Share

  368. TSUDA K, Kanzaki Y, Hoshiga M
    Early cardiac magnetic resonance leads to diagnose the etiology of myocardial infarction with non-obstructive coronary arteries.
    Eur Heart J. 2021 Oct 18. pii: 6400298. doi: 10.1093.
    >> Share

  369. WADSTROM BN, Wulff AB, Pedersen KM, Jensen GB, et al
    Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
    Eur Heart J. 2021 Oct 18. pii: 6399975. doi: 10.1093.
    >> Share

  370. GALLI M, Angiolillo DJ
    Non-opioid analgesics in patients undergoing percutaneous coronary intervention: hype or hope?
    Eur Heart J. 2021;42:4037-4039.
    >> Share

  371. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
    Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study.
    Eur Heart J. 2021 Oct 11. pii: 6386704. doi: 10.1093.
    >> Share

  372. BANNING AP, Serruys P, De Maria GL, Ryan N, et al
    Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
    Eur Heart J. 2021 Oct 7. pii: 6383065. doi: 10.1093.
    >> Share

  373. CREA F
    The challenge of risk stratification in suspected angina, in myocardial infarction without risk factors, and in frail patients.
    Eur Heart J. 2021;42:3807-3811.
    >> Share

  374. CURZEN N, Nicholas Z, Stuart B, Wilding S, et al
    Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial.
    Eur Heart J. 2021;42:3844-3852.
    >> Share

  375. JAFFER FA, Mehilli J, Escaned J
    Left main coronary disease at the bifurcation: should the pendulum swing back towards the provisional stenting approach?
    Eur Heart J. 2021;42:3840-3843.
    >> Share

  376. SENIOR R, Khattar R
    Stress echocardiography: the quest for risk stratification beyond myocardial ischaemia.
    Eur Heart J. 2021;42:3879-3881.
    >> Share

  377. AVIS SR, Vernon ST, Hagstrom E, Figtree GA, et al
    Coronary artery disease in the absence of traditional risk factors: a call for action.
    Eur Heart J. 2021;42:3822-3824.
    >> Share

  378. MENG SW, Ko TY, Hsieh MY
    Simultaneous acute pulmonary and coronary embolism.
    Eur Heart J. 2021;42:3888.
    >> Share

    September 2021
  379. HAN Y
    Long-term outcomes of new-generation coronary stents in China.
    Eur Heart J. 2021 Sep 18. pii: 6372216. doi: 10.1093.
    >> Share

  380. SINHA A, Rahman H, Webb A, Shah AM, et al
    Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
    Eur Heart J. 2021 Sep 16. pii: 6371296. doi: 10.1093.
    >> Share

  381. PETERS SAE, Kluin J
    Why do women do worse after coronary artery bypass grafting?
    Eur Heart J. 2021 Sep 15. pii: 6370651. doi: 10.1093.
    >> Share

  382. LOPEZ-SENDON JL, Cyr DD, Mark DB, Bangalore S, et al
    Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
    Eur Heart J. 2021 Sep 13. pii: 6368943. doi: 10.1093.
    >> Share

  383. BAYES-GENIS A, Diez J
    Transition to heart failure in hypertension: going to the heart of the matter.
    Eur Heart J. 2021 Sep 13. pii: 6369562. doi: 10.1093.
    >> Share

  384. BROWN JM, Zhou W, Weber B, Divakaran S, et al
    Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.
    Eur Heart J. 2021 Sep 7. pii: 6365821. doi: 10.1093.
    >> Share

  385. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    >> Share

    August 2021
  386. CREA F
    Pulmonary embolism, COVID, and bleeding risk in acute coronary syndromes: a Focus Issue on thrombosis and antithrombotic treatment.
    Eur Heart J. 2021;42:3109-3113.
    >> Share

  387. YANG Q, Sun D, Pei C, Zeng Y, et al
    LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project.
    Eur Heart J. 2021;42:3175-3186.
    >> Share

  388. CERRATO E, Giacobbe F, Quadri G, Macaya F, et al
    Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry.
    Eur Heart J. 2021;42:3161-3171.
    >> Share

  389. LUSEBRINK E, Massberg S, Orban M
    The lack of evidence-based therapeutic strategies for left ventricular unloading during venoarterial extracorporeal membrane oxygenation therapy calls for randomized trials.
    Eur Heart J. 2021;42:3105-3106.
    >> Share

  390. KLOECKNER M, Guihaire J, Hascoet S
    Congestive pulmonary oedema during venoarterial extracorporeal membrane oxygenation support: a plea for balloon atrial septostomy.
    Eur Heart J. 2021;42:3103-3104.
    >> Share

  391. DAVIERWALA PM, Gao C, Thuijs DJFM, Wang R, et al
    Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
    Eur Heart J. 2021 Aug 18. pii: 6354120. doi: 10.1093.
    >> Share

  392. GAUDINO M, Di Franco A, Alexander JH, Bakaeen F, et al
    Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
    Eur Heart J. 2021 Aug 2. pii: 6333765. doi: 10.1093.
    >> Share

    July 2021
  393. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
    Early invasive coronary angiography and acute ischaemic heart failure outcomes.
    Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
    >> Share

  394. GOROG DA, Navarese EP, Andreotti F
    Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
    Eur Heart J. 2021 Jul 29. pii: 6330652. doi: 10.1093.
    >> Share

  395. COLLISON D, Didagelos M, Aetesam-Ur-Rahman M, Copt S, et al
    Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial.
    Eur Heart J. 2021 Jul 19. pii: 6323924. doi: 10.1093.
    >> Share

    May 2021
  396. NAVARESE EP, Lansky AJ, Kereiakes DJ, Kubica J, et al
    Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.
    Eur Heart J. 2021 May 18. pii: 6276780. doi: 10.1093.
    >> Share

  397. HILDICK-SMITH D, Egred M, Banning A, Brunel P, et al
    The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).
    Eur Heart J. 2021 May 18. pii: 6276782. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016